Structure of the Rpn13-Rpn2 complex provides insights for Rpn13 and Uch37 as anticancer targets.
Lu, X., Nowicka, U., Sridharan, V., Liu, F., Randles, L., Hymel, D., Dyba, M., Tarasov, S.G., Tarasova, N.I., Zhao, X.Z., Hamazaki, J., Murata, S., Burke, T.R., Walters, K.J.(2017) Nat Commun 8: 15540
- PubMed: 28598414 
- DOI: https://doi.org/10.1038/ncomms15540
- Primary Citation of Related Structures:  
6CO4 - PubMed Abstract: 
Proteasome-ubiquitin receptor hRpn13/Adrm1 binds and activates deubiquitinating enzyme Uch37/UCHL5 and is targeted by bis-benzylidine piperidone RA190, which restricts cancer growth in mice xenografts. Here, we solve the structure of hRpn13 with a segment of hRpn2 that serves as its proteasome docking site; a proline-rich C-terminal hRpn2 extension stretches across a narrow canyon of the ubiquitin-binding hRpn13 Pru domain blocking an RA190-binding surface ...